Diagnosis of COPD in hospitalised patients;Calidad del diagnóstico de la enfermedad pulmonar obstructiva crónica en el ámbito hospitalario

Archivos de Bronconeumologia

Volumn 46, Issue 2, 2010, Pages 64-69

  Pellicer Císcar, Concha ^a   Soler Cataluña, Juan José ^b   Andreu Rodríguez, Ada Luz ^c   Bueso Fabra, Josefa ^d  

^a HOSPITAL FRANCESC DE BORJA   (Spain)

^b Hospital de Requena   (Spain)

^c HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

^d HOSPITAL GENERAL DE CASTELLÓN   (Spain)

Author keywords

COPD diagnosis; Quality health care; Smoking; Spirometry

Indexed keywords

ADULT; AGED; ARTICLE; BRONCHUS OBSTRUCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; SMOKING; SPIROMETRY;

AGED; AGED, 80 AND OVER; AIRWAY OBSTRUCTION; BRONCHIAL DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HOSPITALIZATION; HUMANS; MALE; MEDICAL AUDIT; MEDICINE; MIDDLE AGED; PATIENT DISCHARGE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES; SMOKING; SPAIN; SPIROMETRY;

EID: 75149117642     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbres.2009.10.012     Document Type: Article

References (32)

1. Centres for Disease Control prevention (CDC). Deaths from chronic obstructive pulmonary disease - United States, 2000-2005. MMWR Morb Mortal Wkly Rep 57 (2008) 1229-1232
2. Centres for Disease Control prevention (CDC). Smoking-attributable mortality, years of potential life lost, and productivity losses-United States, 200-2004. MMWR Morb Mortal Wkly Rep 57 (2008) 1226-1228
3. Murray C.J.L., and López A.D. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 349 (1997) 1269-1276
4. Chapman K.R., Mannino D.M., Soriano J.A., Vermeire P.A., Buist A.S., Thun M.J., et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 27 (2006) 188-207
5. Sobradillo Peña V., Miravitlles M., Gabriel R., Jiménez-Ruiz C.A., Villasante C., Masa J.F., et al. Geographic variations in prevalence and underdiagnosis of COPD: Results of the IBERPOC multicentre epidemiological study. Chest 118 (2000) 981-989
6. Izquierdo J.L. The burden of COPD in Spain: Results from the Confronting COPD survey. Respir Med 97 (2003) 61S-69S
7. Peces-Barba G., Barberà J.A., Agustí A., Casanova C., Casas A., Izquierdo J.L., et al. Guía clínica SEPAR-ALAT de diagnóstico y tratamiento de la EPOC. Arch Bronconeumol 44 (2008) 271-281
8. Rabe K.F., Hurd S., Anzueto A., Barnes P.J., Buist S.A., Calverley P., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. GOLD executive summary. Am J Respir Crit Care Med 176 (2007) 532-555
9. National Institute for Clinical Excellence (NICE). Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 59 (2004) 1-232
10. Bellamy D., Bouchard J., Henrichsen S., Johansson G., Langhammer A., Reie J., et al., International Primary Care Respiratory Group (IPCRG). Guidelines: Management of chronic obstructive pulmonary disease (COPD). Prim Care Respir J 15 (2006) 7-9
11. Celli B.R., MacNee W., and and committee members. Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper. Eur Respir J 23 (2004) 932-946
12. Soler-Cataluña J.J., Calle M., Cosío B.G., Marín J.M., Monsó E., Alfageme I., and en representación del Comité de Calidad Asistencial de la SEPAR y del Área de trabajo EPOC de la SEPAR. Estándares de calidad asistencial en la EPOC. Arch Bronconeumol 45 (2009) 196-203
13. De Miguel Diez J., Izquierdo Alonso J.L., Molina París J., Rodríguez González-Moro J.M., de Lucas Ramos P., and Gaspar Alonso-Vega G. Fiabilidad del diagnóstico de la EPOC en atención primaria y neumología en España. Factores predictivos. Arch Bronconeumol 39 (2003) 203-208
14. Bolton C.E., Ionescu A.A., Edwards P.H., Faulkner T.A., Edwards S.M., and Shale D.J. Attaining a correct diagnosis of COPD in general practice. Respir Med 99 (2005) 493-500
15. Matheson M.C., Abeysena C., Raven J.M., Skoric B., Johns D.P., Abramson M.J., et al. How have we managing chronic obstructive pulmonary disease in Australia?. Intern Med J 36 (2006) 92-99
16. Murlaski R.A., Asch S.M., Shrank W.H., Kerr E.A., Setodji C.M., Adams J.L., et al. The quality of obstructive lung disease care for adults in the United States as measured by adherence to recommended processes. Chest 130 (2006) 1844-1850
17. Naberan K., De la Roza C., Lamban M., Gobartt E., Martín A., and Miravitlles M. Utilización de la espirometría en el diagnóstico y tratamiento de la EPOC en Atención Primaria. Arch Bronconeumol 42 (2006) 638-644
18. Lee T.A., Bartle B., and Weiss K.B. Spirometry use in clinical practice following diagnosis of COPD. Chest 129 (2006) 1509-1515
19. Joo M.J., Lee T.A., and Weis K.B. Geographic variation of spirometry use in newly diagnosed COPD. Chest 134 (2008) 38-45
20. Talamo C., Montes de Oca M., Halbert R., Pérez-Padilla R., Jardim Jr. B., Muiño A., et al. Diagnostic labelling of COPD in five Latin American cities. Chest 131 (2007) 60-67
21. Sichletidis L., Chloros D., Spyratos D., Chatzidimitriou N., Chatziiliadis P., Protopappas N., et al. The validity of the diagnosis of chronic obstructive pulmonary disease in general practice. Prim Care Respir J 16 (2007) 82-88
22. Registro de altas de hospitalización - CMBD. Sistema Nacional de Salud. Febrero 2008 [consultado 20/3/2009]. Disponible en: http://pestadistico.msc.es/PEMSC25/Docs/MANUAL%20DE%20DEFINICIONES%20CMBD_Mar08.pdf
23. Hueto J., Cebollero P., Pascal I., Cascante J.A., Eguía V.M., Teruel F., et al. La espirometría en atención primaria en Navarra. Arch Bronconeumol 42 (2006) 326-331
24. Roberts C.M., Ryland I., Lowe D., Kelly Y., Bucknall C.E., Pearson M.G., on behalf of the audit sub-committee of the Standards of care Committee, and British Thoracic Society and the Clinical Effectiveness and Evaluation Unit of the Royal College of Physicians. Audit of acute admissions of COPD: Standards of care and management in the hospital setting. Eur Respir J 17 (2001) 343-349
25. Roberts C.M., Barnes S., Lowe D., Pearson M.G., on behalf of the Clinical Effectiveness Evaluation Unit, and Royal College of Physicians and the audit subcommittee of the British Thoracic Society. Evidence for a link between mortality in acute COPD and hospital type and resources. Thorax 58 (2003) 947-949
26. Price L.C., Lowe D., Hosker H.S., Anstey K., Pearson M.G., Roberts C.M., and British Thoracic Society and the Clinical Effectiveness and Evaluation Unit of the Royal College of Physicians Clinical Effectiveness Evaluation Unit (CEEU). UK National COPD Audit 2003: Impact of hospital resources and organisation of care on patient outcome following admission for acute COPD exacerbation. Thorax 61 (2006) 837-842
27. Miratvilles M., de la Roza C., Naberan K., Lamban M., Gobartt E., Martín A., et al. Problemas con el diagnóstico de la EPOC en atención primaria. Arch Bronconeumol 42 (2006) 3-8
28. Han M.K., Postma D., Mannino D.M., Giardino N.D., Buist S., Curtis J.L., et al. Gender an chronic obstructive pulmonary disease. Why it matters?. Am J Respir Crit Care Med 176 (2007) 1179-1184
29. Cote C.G., and Chapman K.R. Diagnosis and treatment considerations for women with COPD. Int J Clin Practi 63 (2009) 486-493
30. De Torres J.P., Cote C.G., López M.V., Casanova C., Díaz O., Marín J.M., et al. Sex differences in mortality in patients with COPD. Eur Respir J 33 (2009) 528-535
31. Burgos F. ¿Son compatibles la calidad y el uso extensivo de la espirometría?. Arch Bronconeumol 42 (2006) 311-313
32. Tura A., Santini P., Longo D., and Quareni L. A telemedicina instrument for home monitoring of patients with chronic respiratory diseases. Ann Ist Super Sanita 43 (2007) 101-109